Brand Name | Status | Last Update |
---|---|---|
follistim aq | Biologic Licensing Application | 2025-02-03 |
gonal-f | Biologic Licensing Application | 2024-07-15 |
gonal-f rff | Biologic Licensing Application | 2023-11-20 |
gonal-f rff redi-ject | Biologic Licensing Application | 2025-04-03 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fertilization in vitro | D005307 | — | — | — | — | — | 1 | — | 1 |
Oocyte retrieval | D054315 | — | — | — | — | — | 1 | — | 1 |
Blastocystis | D016844 | — | — | — | — | — | 1 | — | 1 |
Embryo research | D033041 | — | — | — | — | — | 1 | — | 1 |
Drug common name | Follitropin |
INN | follitropin alfa |
Description | Gonadotropin preparations are drugs that mimic the physiological effects of gonadotropins, used therapeutically mainly as fertility medication for ovarian hyperstimulation and ovulation induction. For example, the so-called menotropins consist of LH and FSH extracted from human urine from menopausal women. There are also recombinant variants.
|
Classification | Protein |
Drug class | tricyclic compounds; atropine derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |